Table 4.

Costs, effects, and cost effectiveness ratios for most cost effective interventions in Afr-E in 2000

Intervention package	Description (coverage) of package	Additional interventions*	Yearly cost ($Int millions)	DALYs averted per year (millions)	ACER ($Int per DALY averted)	ICER ($Int per DALY averted)
A1	Vitamin A and zinc fortification (95%)	Vitamin A and zinc fortification of food staple (95%)	23	1	19	19
A2	A1 + measles immunisation (80%)	Measles immunisation	72	3	25	29
A3	A2 + measles immunisation (95%)	Measles immunisation	91	3	28	58
A4	A3 + case management of pneumonia (80%)	Case management of pneumonia	261	6	47	73
A5	Vitamin A and zinc supplementation + case management of pneumonia (80%) + measles immunisation (95%)	Fortification replaced by supplementation	386	7	55	85
A6	A5 + oral rehydration therapy (80%)	Oral rehydration therapy for diarrhoea	772	11	72	106
A7	A6 (95%)	Coverage expanded to 95%	1167	12	95	243
A8	A7 + provision of supplementary food and nutrition counselling, and growth monitoring and promotion (95%)	Provision of supplementary food and nutritional counselling, growth monitoring and promotion	2 797	12	225	12 791

DALY=disability adjusted life year; ICER=incremental cost effectiveness ratio; ACER=average cost effectiveness ratio; Afr-E=WHO defined region comprising countries in sub-Saharan Africa with high child mortality.

^*In order of cost effectiveness.